NEJM -

"Antibiotic Treatment Strategies for Community-Acquired Pneumonia in Adults"

"CONCLUSIONS

Among patients with clinically suspected CAP admitted to non-ICU wards, a strategy of preferred empirical treatment with beta-lactam monotherapy was noninferior to strategies with a beta-lactam–macrolide combination or fluoroquinolone monotherapy with regard to 90-day mortality. (Funded by the Netherlands Organization for Health Research and Development; CAP-START ClinicalTrials.gov number,NCT01660204.)"

http://www.nejm.org/doi/full/10.1056/NEJMoa1406330